AGEPX | EADOX | AGEPX / EADOX | |
Total Expense Ratio | 1.40 | 1.15 | 122% |
Annual Report Gross Expense Ratio | 1.40 | 1.15 | 122% |
Fund Existence | 12 years | 10 years | - |
Gain YTD | 13.499 | 11.590 | 116% |
Front Load | N/A | 3% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.24B | 3.9B | 32% |
Annual Yield % from dividends | 10.52 | 7.89 | 133% |
Returns for 1 year | 16.07 | 14.36 | 112% |
Returns for 3 years | 60.42 | 53.07 | 114% |
Returns for 5 years | 47.05 | 39.58 | 119% |
Returns for 10 years | 94.39 | 94.88 | 99% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFAX | 14.53 | 0.10 | +0.69% |
AlphaCentric Life Sciences & Hlthcare A | |||
PLCGX | 18.43 | 0.10 | +0.55% |
Principal LargeCap Growth I R6 | |||
NQVAX | 60.44 | 0.31 | +0.52% |
Nuveen Multi Cap Value A | |||
IBNYX | 25.94 | 0.07 | +0.27% |
Macquarie Balanced Fund Class Y | |||
EMFIX | 13.67 | -0.06 | -0.44% |
Ashmore Emerging Markets Equity Instl |